CYP46A1 and Alzheimer disease: Moreover, upregulation of neuronal cholesterol through inhibition of CYP46A1, cholesterol 24-hydroxylase which converts cholesterol to 24S-hydroxycholesterol, exacerbated AD-related pathology by inducing recruitment of APP into lipid rafts, resulting in enhanced Aβ production and cognitive deficits in an AD mouse model [53].